Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Almonty Industries Reaches Key Milestone with First Ore Shipment from Sangdong

Robert Sasse by Robert Sasse
January 27, 2026
in Analysis, Asian Markets, Commodities, Industrial
0
Almonty Stock
0
SHARES
45
VIEWS
Share on FacebookShare on Twitter

Almonty Industries has successfully moved its flagship Sangdong tungsten mine in South Korea from construction into active production. This critical transition marks a significant step in the company’s strategy to become a major supplier of tungsten outside of China, a goal increasingly prioritized by Western nations. The company’s ability to navigate a complex market environment now comes into sharper focus.

A Tightening Market and Strategic Positioning

The commencement of operations at Sangdong occurs against a backdrop of dramatic price movements and shifting supply chains. Throughout 2025, the price of tungsten surged by over 160%. This rally is primarily attributed to export restrictions from China, which currently accounts for more than 80% of global production.

Further market pressure stems from U.S. policy: starting in 2027, a ban on importing Chinese tungsten for defense procurement will take effect. Almonty has proactively secured binding offtake agreements, including long-term commitments to supply tungsten oxide for U.S. defense applications. The company has articulated an ambitious long-term target: to supply a minimum of 40% of the non-China tungsten market.

Operational Progress Across the Portfolio

The first truckload of ore was extracted and transported from the Sangdong site in December 2025, officially initiating operational mining. The project is now in its final stage before reaching planned full commercial production. Sangdong is projected to become one of the largest and longest-life tungsten mines outside China. The focus for 2026 is ramping up Phase 1 to full capacity, with a Phase II expansion targeted for 2027.

Should investors sell immediately? Or is it worth buying Almonty?

Concurrently, Almonty is advancing its other key assets:
* At the Panasqueira mine in Portugal, an extensive drilling program is underway to extend the operation’s mine life.
* The recently acquired Gentung Browns Lake project in Montana, USA, is slated to be production-ready by the second half of 2026.

Financial Foundation for Growth

To fund its expansion, Almonty significantly strengthened its capital base in 2025. The company completed a U.S. initial public offering and listed on the Nasdaq exchange. Through two enlarged equity placements, it raised gross proceeds of approximately $219.4 million.

These funds are earmarked to finance the continued build-out of Sangdong, exploration at Panasqueira, and development preparations for the Gentung Browns Lake project. The coming period will be decisive, testing whether the production ramp-up proceeds as scheduled and if Almonty can fulfill its existing offtake agreements within the current market dynamics.


Key Takeaways:

  • Production Commences: Active ore extraction began at the Sangdong tungsten mine in December 2025.
  • Market Context: Tungsten prices increased by 160% in 2025, driven by Chinese export limits and an impending U.S. ban on Chinese tungsten for defense use starting in 2027.
  • Strategic Goal: Almonty aims to become a primary tungsten source for the U.S. and its allies, targeting 40% of the non-China supply.
  • 2026 Roadmap: Full commercial ramp-up at Sangdong, expansion work at Panasqueira, and production preparation at Gentung Browns Lake.
  • Capital Raise: Approximately $219.4 million in new capital was secured in 2025 via two equity offerings and the Nasdaq listing.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from February 7 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Graftech Stock
Commodities

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Next Post
CureVac Stock

An Era Concludes: CureVac's Stock Market Journey Ends Following BioNTech Acquisition

US Goldmining Stock

Riding the Gold Wave: US Goldmining's Strategic Position in a Record Market

BYD Stock

BYD's Global Ambitions: Can Overseas Growth Offset Domestic Headwinds?

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com